In terms of tumor factors, about two thirds of the HCC tumors (68.5%) in the AFP group were in previously established blind spots of the US test, including hepatic dome, area under the rib, caudate lobe, and tip of the lateral segment of the left lobe. The gene discussed is AFP; the disease is neoplasm.